Clinical trial
Receptor for Advanced Glycation End Products (RAGE) Polymorphisms In Inflammatory Bowel Disease
NCT04286659 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Receptor for Advanced Glycation End Products (RAGE) Polymorphisms In Inflammatory Bowel Disease
- Lead sponsor
- Assiut University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 1, 2020
- Completion date
- December 31, 2023
- Enrollment
- 180 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.